Home | Welcome to Contract Pharma   
Last Updated Tuesday, September 2 2014
Print

Warning Letter



An FDA post-audit letter notifying the manufacture of adverse inspections findings requiring a reply with defined plans for remediation.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On